三绒毛膜和双绒毛膜三胎妊娠行胚胎减灭术与期待治疗的流产或早产风险:系统综述与Meta分析
该系统综述纳入8项研究共249例双绒毛膜三羊膜囊(DCTA)和1167例三绒毛膜三羊膜囊(TCTA)三胎妊娠,比较胚胎减灭(ER)至双胎与期待治疗的流产(<24周)和早产(<34周)风险。TCTA中ER与早产风险降低相关(17.3% vs 50.2%,RR=0.36,95%CI 0.28-0.48),流产风险无显著增加(8.1% vs 7.4%,RR=1.08,95%CI 0.58-1.98);DCTA中结果不确定。
要点
- TCTA三胎妊娠行ER至双胎与期待治疗相比,早产(<34周)风险降低(17.3% vs 50.2%,RR=0.36,95%CI 0.28-0.48)。
- TCTA中ER未显著增加流产(<24周)风险(8.1% vs 7.4%,RR=1.08,95%CI 0.58-1.98)。
- DCTA三胎妊娠中ER与期待治疗的流产和早产风险均无显著差异,Meta分析结果不确定。
核心结论
- 在TCTA三胎妊娠中,ER至双胎与早产(<34周)风险降低相关,且未显著增加流产(<24周)风险;在DCTA三胎妊娠中,结果不确定。
研究设计与样本
- 遵循PRISMA指南的系统综述与Meta分析,检索2000年至2016年英文文献,数据库检索于2017年1月8日执行。
- 纳入8项研究,共249例DCTA和1167例TCTA三胎妊娠,仅纳入同时包含期待治疗和ER至双胎两组的研究。
- 比较ER至双胎与期待治疗的流产(<24周)和早产(<34周)率。
主要发现
- TCTA期待治疗组(n=501)流产率和早产率分别为7.4%和50.2%。
- TCTA中ER至双胎组(n=666)早产率17.3% vs 期待治疗组50.2%(RR=0.36,95%CI 0.28-0.48),流产率8.1% vs 7.4%(RR=1.08,95%CI 0.58-1.98),无显著增加。
- DCTA期待治疗组(n=200)流产率和早产率分别为8.5%和51.9%。
- DCTA中ER至双胎(减灭独立胎盘胎儿n=15或单绒毛膜双胎之一n=34)与期待治疗相比,流产率8.5% vs 13.3%(P=0.628,RR=1.22,95%CI 0.38-3.95),早产率51.9% vs 46.2%(P=0.778,RR=0.5,95%CI 0.04-5.7),均无显著差异。
临床怎么用
- 在缺乏随机试验的情况下,系统综述数据似乎是早孕期咨询不同方案的最佳现有证据。
局限性
- 文献检索未发现TCTA或DCTA妊娠中ER与期待治疗的随机对照试验。
- 仅纳入少数样本量小且存在偏倚的论文,且遗漏了非英文出版物。
- 尽管有严格的纳入和排除标准,发表偏倚仍明显。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is pregnancy outcome in triplet pregnancies improved with embryo reduction (ER) to twins compared to expectant management? SUMMARY ANSWER: In trichorionic triplet pregnancies, ER to twins reduces the risk of preterm birth (<34 weeks) without significantly increasing the risk of miscarriage (<24 weeks), whereas in dichorionic triplet pregnancies, the results are inconclusive. WHAT IS KNOWN ALREADY: Triplet pregnancies are associated with a high risk of miscarriage and preterm birth. ER can ameliorate these conditions in higher order multiple gestations but is still controversial in triplets. STUDY DESIGN, SIZE, DURATION: This study aimed to conduct a systematic review, following the PRISMA guidelines, and critically appraise ER at 8-14 weeks of gestation in both trichorionic triamniotic (TCTA) and dichorionic triamniotic (DCTA) pregnancies. Selective ER to twins was compared with expectant management, focusing on the risks of miscarriage and preterm birth. The computerized database search was performed on 8 January 2017. Overall, from 25 citations of relevance, eight studies with a total of 249 DCTA and 1167 TCTA pregnancies fulfilled the inclusion criteria. PARTICIPANTS/MATERIALS, SETTING, METHODS: A comprehensive computerized systematic literature search of all English language studies between 2000 and 2016 was performed in PubMed, EMBASE, Scopus, Evidence Based Medicine Reviews (Cochrane Database and Cochrane Central Register of Controlled Trials) and Google Scholar. Relevant article reference lists were hand searched. The management options were compared for rates of miscarriage <24 weeks and preterm birth <34 weeks. Only studies with both expectant management and ER to twins were included in the analysis. The quality of each individual article was critically appraised and appropriate statistical methods were used to extract results. MAIN RESULTS AND THE ROLE OF CHANCE: In TCTA pregnancies managed expectantly (n = 501), the rates of miscarriage and preterm birth were 7.4 and 50.2%, respectively. Meta-analysis demonstrated that ER to twins in TCTA pregnancies (n = 666) was associated with a lower risk (17.3 versus 50.2%) of preterm birth (RR = 0.36, 95% CI: 0.28-0.48), whereas the risk of miscarriage (8.1% versus 7.4%) did not significantly increase (RR = 1.08, 95% CI: 0.58-1.98). In DCTA triplets managed expectantly (n = 200), the rates of miscarriage and preterm birth were 8.5 and 51.9%, respectively. Although the meta-analysis was inconclusive, it suggested that ER to twins in DCTA triplets, either of the foetus with a separate placenta (n = 15) or one of the monochorionic pair (n = 34), was neither significantly associated with an increased risk of miscarriage (8.5 versus 13.3%, P = 0.628 and RR = 1.22, 95% CI: 0.38-3.95, respectively) nor with a lower risk of preterm birth (51.9 versus 46.2%, P = 0.778 and RR = 0.5, 95% CI: 0.04-5.7, respectively). LIMITATIONS, REASONS FOR CAUTION: No randomized controlled trials of ER versus expectant management in TCTA or DCTA pregnancies were identified from our literature search. We were able to include only a handful of papers with small sample sizes and suffering from bias, and non-English publications were missed. Irrespective of the strict inclusion and exclusion criteria, publication bias was evident. WIDER IMPLICATIONS OF THE FINDINGS: The greatest strength of our systematic review is that, contrary to the existing literature, it only included studies with both the intervention and expectant arm. Our results are in agreement with current literature. In TCTA pregnancies, ER to twins is associated with a lower risk of preterm birth but is not associated with a higher risk of miscarriage. In the absence of a randomized trial, the data from systematic reviews appear to be the best existing evidence for counselling in the first trimester on the different options available. Finally, in DCTA pregnancies, indications exist that ER (of one of the MC pair) to twins could possibly reduce the risk of preterm birth without increasing the risk of miscarriage. STUDY FUNDING/COMPETING INTEREST(S): None to declare. REGISTRATION NUMBER: N/A.
引用
- Anthoulakis C, Dagklis T, Mamopoulos A, et al. Risks of miscarriage or preterm delivery in trichorionic and dichorionic triplet pregnancies with embryo reduction versus expectant management: a systematic review and meta-analysis. Hum Reprod. 2017. PMID: 28444191. doi:10.1093/humrep/dex084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。